| 別品名 |
Epilepsy progressive myoclonus type 2 Lafora disease (laforin) antibody; Epilepsy progressive myoclonus type 2A Lafora disease (laforin) antibody; EPM2 antibody; Epm2a antibody; Epm2a gene antibody; EPM2A_HUMAN antibody; Lafora PTPase antibody; Laforin antibody; LAFPTPase antibody; LD antibody; LDE antibody; MELF antibody; RP3-466P17.2 antibody
|
| 抗原部位 |
a.a.244-331
|
| 種由来 |
Human
|
| 標識物 |
Unlabeled
|
| 精製度 |
Affinity Purified
|
| 適用 |
Enzyme Linked Immunosorbent Assay
Immunohistochemistry
|
| 免疫動物 |
Rabbit
|
| 抗体クラス |
IgG
|
| 交差種 |
Human
|
| Accession No.(Gene/Protein) |
O95278
|
| 形状 |
液状
|
| 参考文献 |
[1]Lafora disease in the Indian population: EPM2A and NHLRC1 gene mutations and their impact on subcellular localization of laforin and malin."Singh S., Satishchandra P., Shankar S.K., Ganesh S.Hum. Mutat. 29:E1-12(2008) . [2]Mutations in the NHLRC1 gene are the common cause for Lafora disease in the Japanese population."Singh S., Suzuki T., Uchiyama A., Kumada S., Moriyama N., Hirose S., Takahashi Y., Sugie H., Mizoguchi K., Inoue Y., Kimura K., Sawaishi Y., Yamakawa K., Ganesh S. J. Hum. Genet. 50:347-352(2005). [3]Loss of function of the cytoplasmic isoform of the protein laforin (EPM2A) causes Lafora progressive myoclonus epilepsy."Ianzano L., Young E.J., Zhao X.C., Chan E.M., Rodriguez M.T., Torrado M.V., Scherer S.W., Minassian B.A.Hum. Mutat. 23:170-176(2004)
|
|
※サムネイル画像をクリックすると拡大画像が表示されます。
Immunohistochemistry of paraffin-embedded human salivary gland tissue using CSB-PA007738ESR1HU at dilution of 1:100
Immunohistochemistry of paraffin-embedded human kidney tissue using CSB-PA007738ESR1HU at dilution of 1:100
|
|
|
|
Immunohistochemistry of paraffin-embedded human salivary gland tissue using CSB-PA007738ESR1HU at dilution of 1:100
|
|
|
| メーカー |
品番 |
包装 |
|
CSB
|
CSB-PA007738ESR1HU
|
50 UL
|
※表示価格について
| 当社在庫 |
なし
|
| 納期目安 |
2週間程度
|
| 保存温度 |
-２０℃
|
|
